Coupling of a Novel TIMP3 Peptide to Carboxypeptidase G2 for Pro-Drug Activation at the Tumour Site

Broad-spectrum cytotoxic drugs have been used in cancer therapy for decades. However, their lack of specificity to cancer cells often results in serious side-effects, limiting efficacy. For this reason, antibodies have been used to attempt to specifically target cytotoxic drugs to tumours. One such...

Descripción completa

Detalles Bibliográficos
Autores principales: Aldughaim, Mohammed S., Alsaffar, Fatimah, Barker, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865317/
https://www.ncbi.nlm.nih.gov/pubmed/33504102
http://dx.doi.org/10.3390/molecules26030625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865317/
https://www.ncbi.nlm.nih.gov/pubmed/33504102
http://dx.doi.org/10.3390/molecules26030625

Ejemplares similares